Cellebrite DI (CLBT) Balance Sheet: Assets & Liabilities

Cellebrite DI (CLBT) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Cellebrite DI reported total assets of $938.85M and total liabilities of $454.53M. Shareholders' equity was $484.32M, up 44.1% from $336.02M a year earlier. Total debt stood at $22.67M against $437.05M in cash and short-term investments, a net cash position of $414.38M. That puts debt-to-equity at 0.05, compared with 0.03 a year earlier.

Cellebrite DI Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Cellebrite DI Ltd. (CLBT) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Current Assets
Cash and Cash Equivalents	124.46	191.66	189.52	87.65	145.97	128.71	76.55
Short-Term Investments	312.59	255.56	113.41	95.98	35.59	108.93	123.71
Cash & Short-Term Investments	437.05	447.22	302.92	183.62	181.57	237.64	200.25
Accounts Receivable	104.97	82.36	77.27	78.76	67.51	66.32	44.24
Inventory	7.60	8.94	9.94	10.18	6.51	4.75	3.96
Other Current Assets	4.46	29.07	31.95	23.37	17.63	15.56	13.43
Total Current Assets	575.85	567.59	422.08	295.93	273.21	324.27	261.88
Non-Current Assets
Property, Plant & Equipment (Net)	38.52	27.60	30.16	32.91	16.76	16.11	14.82
Long-Term Investments	97.96	36.60	28.86	22.13	0.00	0.00	0.00
Goodwill	119.56	28.71	26.83	26.83	26.83	9.46	0.00
Intangible Assets	81.47	11.31	10.59	11.25	11.23	6.61	0.00
Other Non-Current Assets	14.62	7.68	14.37	14.24	11.76	0.57	0.45
Total Non-Current Assets	363.00	122.97	110.80	107.36	66.57	40.12	18.36
Total Assets	938.85	690.57	532.89	403.29	339.78	364.39	280.24
Current Liabilities
Accounts Payable	16.83	11.08	8.28	4.61	9.55	4.73	5.36
Short-Term Debt	4.00	4.13	4.97	5.00	0.00	0.00	0.00
Accrued Liabilities	57.84	56.59	44.85	45.45	54.04	-	-
Deferred Revenue	278.24	217.64	195.73	152.71	122.98	106.10	69.79
Other Current Liabilities	70.59	61.91	1.09	1.63	0.91	41.94	22.74
Total Current Liabilities	369.66	295.50	253.82	207.78	186.57	159.38	99.16
Non-Current Liabilities
Long-Term Debt	18.67	6.84	9.16	10.35	0.00	0.00	0.00
Other Non-Current Liabilities	16.68	6.95	235.69	111.30	226.56	107.76	103.32
Total Non-Current Liabilities	84.88	59.05	244.85	121.65	226.56	141.20	122.25
Total Liabilities	454.53	354.55	498.67	329.43	413.13	300.58	221.41
Stockholders' Equity
Retained Earnings	-86.54	-164.86	118.14	199.24	78.44	28.34	32.56
Accumulated Other Comprehensive Income	2.22	2.09	1.05	0.33	1.37	1.32	0.80
Treasury Stock	0.09	0.09	0.09	0.09	0.09	-	-
Additional Paid-in Capital	568.72	498.80	-84.90	-125.62	-153.16	34.14	25.46
Shares Outstanding	248.58	234.52	203.23	193.01	187.68	-	-
Total Stockholders' Equity	484.32	336.02	34.21	73.87	-73.35	63.80	58.83
Total Liabilities & Equity	938.85	690.57	532.89	403.29	339.78	364.39	280.24

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Cellebrite DI Balance Sheet

How much debt does Cellebrite DI have?

Cellebrite DI had total debt of $22.67M as of Dec 31, 2025, against $437.05M in cash and short-term investments. Its debt-to-equity ratio was 0.05. Total debt was $10.97M a year earlier.

What are Cellebrite DI's total assets?

Cellebrite DI reported total assets of $938.85M as of Dec 31, 2025, up 36.0% from $690.57M a year earlier. Total liabilities were $454.53M.

What is Cellebrite DI's shareholders' equity?

Cellebrite DI's shareholders' equity was $484.32M as of Dec 31, 2025, or about $1.95 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition